Cupricyclins, novel redox-active metallopeptides based on conotoxins scaffold

PLoS One. 2012;7(2):e30739. doi: 10.1371/journal.pone.0030739. Epub 2012 Feb 3.

Abstract

Highly stable natural scaffolds which tolerate multiple amino acid substitutions represent the ideal starting point for the application of rational redesign strategies to develop new catalysts of potential biomedical and biotechnological interest. The knottins family of disulphide-constrained peptides display the desired characteristics, being highly stable and characterized by hypervariability of the inter-cysteine loops. The potential of knottins as scaffolds for the design of novel copper-based biocatalysts has been tested by engineering a metal binding site on two different variants of an ω-conotoxin, a neurotoxic peptide belonging to the knottins family. The binding site has been designed by computational modelling and the redesigned peptides have been synthesized and characterized by optical, fluorescence, electron spin resonance and nuclear magnetic resonance spectroscopy. The novel peptides, named Cupricyclin-1 and -2, bind one Cu(2+) ion per molecule with nanomolar affinity. Cupricyclins display redox activity and catalyze the dismutation of superoxide anions with an activity comparable to that of non-peptidic superoxide dismutase mimics. We thus propose knottins as a novel scaffold for the design of catalytically-active mini metalloproteins.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Binding Sites
  • Calcium Channel Blockers
  • Conotoxins / chemistry*
  • Copper / metabolism
  • Drug Design
  • Metalloproteins / chemical synthesis
  • Metalloproteins / chemistry*
  • Metalloproteins / genetics
  • Neurotoxins
  • Oxidation-Reduction
  • Peptides / chemistry*
  • Protein Engineering

Substances

  • Calcium Channel Blockers
  • Conotoxins
  • Metalloproteins
  • Neurotoxins
  • Peptides
  • Copper